CYNTHIA SMITH: Open Payments
NPI 1679820799 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 64 payments from 14 companies in 2025. Trend: 2023 $178 · 2024 $712 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 11 | $245 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $196 |
| Phathom Pharmaceuticals, Inc. | 6 | $195 |
| GENZYME CORPORATION | 9 | $187 |
| Aimmune Therapeutics, Inc. | 9 | $176 |
| Ipsen Biopharmaceuticals, Inc | 4 | $77 |
| QOL Medical, LLC | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $21 |
Products named: IBSRELA, DUPIXENT, VOQUEZNA, ZENPEP, XIFAXAN, IQIRVO, Sucraid, ENTYVIO.
Industry payments across MS — which companies pay providers there.
